340 related articles for article (PubMed ID: 24630001)
1. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
J Am Acad Dermatol; 2014 Jun; 70(6):1083-7. PubMed ID: 24630001
[TBL] [Abstract][Full Text] [Related]
2. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
[TBL] [Abstract][Full Text] [Related]
3. Duration of Efficacy Increases with the Repetition of Botulinum Toxin A Injections in Primary Axillary Hyperhidrosis: A 15-year Study in 117 Patients.
Berthin C; Maillard H
Acta Derm Venereol; 2019 Dec; 99(13):1237-1240. PubMed ID: 31453629
[TBL] [Abstract][Full Text] [Related]
4. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
Maillard H; Briand N; Bara C; Celerier P
Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
8. Durability of botulinum toxin treatment for axillary hyperhidrosis.
Moffat CE; Hayes WG; Nyamekye IK
Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
[TBL] [Abstract][Full Text] [Related]
9. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC
Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
11. Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
Alvarez MA; Ruano J; Gómez FJ; Casas E; Baamonde C; Salvatierra A; Moreno JC
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e282-8. PubMed ID: 22827710
[TBL] [Abstract][Full Text] [Related]
12. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
[TBL] [Abstract][Full Text] [Related]
13. Commenting on: "Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis".
Comite SL; Smith K
J Am Acad Dermatol; 2015 Jan; 72(1):201. PubMed ID: 25497933
[No Abstract] [Full Text] [Related]
14. Reply to: "Commenting on: Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis".
Lecouflet M; Maillard H
J Am Acad Dermatol; 2015 Jan; 72(1):201. PubMed ID: 25497932
[No Abstract] [Full Text] [Related]
15. [Botulinum toxin in the treatment of focal hyperhidrosis].
Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
[TBL] [Abstract][Full Text] [Related]
16. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
17. Palmar hyperhidrosis: long-term follow-up of nine children and adolescents treated with botulinum toxin type A.
Coutinho dos Santos LH; Gomes AM; Giraldi S; Abagge KT; Marinoni LP
Pediatr Dermatol; 2009; 26(4):439-44. PubMed ID: 19689521
[TBL] [Abstract][Full Text] [Related]
18. Results of a 10-year follow-up study of botulinum toxin A therapy for primary axillary hyperhidrosis in Australia.
Rosen R; Stewart T
Intern Med J; 2018 Mar; 48(3):343-347. PubMed ID: 29512329
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A therapy for palmar and digital hyperhidrosis.
Solomon BA; Hayman R
J Am Acad Dermatol; 2000 Jun; 42(6):1026-9. PubMed ID: 10827408
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A for palmar hyperhidrosis.
Wollina U; Karamfilov T
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):555-8. PubMed ID: 11843216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
